Summary

Digital Pathology Market Trends and Forecast
The future of the global digital pathology market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The global digital pathology market is expected to reach an estimated $1,630.8 million by 2028 with a CAGR of 10.3% from 2023 to 2028. The major drivers for this market are increasing demand of digital pathology to enhance lab efficiency, growing incidence of cancer, and increasing investments in new digital pathology system by industry players across the globe.

Digital Pathology Market by Segment
The study includes a forecast for the global digital pathology market by product, type, application, end use, and region, as follows:
Digital Pathology Market by Product [Value ($M) Shipment Analysis from 2017 to 2028]:
• Scanners
o Brightfield
o Other Scanners
• Software
o Integrated Software
o Standalone Software
• Information Management Software
• Image Analysis Software
• Storage Systems
Digital Pathology Market by Type [Value ($M) Shipment Analysis from 2017 to 2028]:
• Human Pathology
• Veterinary Pathology
Digital Pathology Market by Application [Value ($M) Shipment Analysis from 2017 to 2028]:
• Drug Discovery
• Disease Diagnosis
• Training & Education
Digital Pathology Market by End Use [Value ($M) Shipment Analysis from 2017 to 2028]:
• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes
Digital Pathology Market by Region [Value ($M) Shipment Analysis from 2017 to 2028]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Digital Pathology Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital pathology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital pathology companies profiled in this report include.
• Leica Biosystems
• Koninklijke Philips N.V.
• Hamamatsu Photonics
• F. Hoffmann-La Roche
• 3DHISTECH
• Apollo Enterprise Imaging
• XIFIN
• Visiopharm A/S
• Aiforia Technologies Oy
• Akoya Biosciences
• Corista

Digital Pathology Market Insights
• Lucintel forecasts that scanners will remain the larger segment over the forecast period because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.
• Pharmaceutical & biotechnology companies are expected to remain the largest segment due increasing use of digital pathology in various applications, such as bio banking, biopharmaceutical studies, molecular assays, and in the development of individualized medicine.
• North America will remain the largest region due to the increasing prevalence of cancer, growing adoption of digital imaging and presence of key market players in the region.

Features of the Digital Pathology Market
• Market Size Estimates: Digital pathology market size estimation in terms of value ($M)
• Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Digital pathology market size by various segments, such as by product, type, application, end use, and region
• Regional Analysis: Digital pathology market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by product, type, application, end use, and regions for the digital pathology market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the digital pathology market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ
Q1. What is the digital pathology market size?
Answer: The global digital pathology market is expected to reach an estimated $1,630.8 million by 2028.
Q2. What is the growth forecast for digital pathology market?
Answer: The global digital pathology market is expected to grow with a CAGR of 10.3% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the digital pathology market?
Answer: The major drivers for this market are increasing demand of digital pathology to enhance lab efficiency, growing incidence of cancer, and increasing investments in new digital pathology system by industry players across the globe.
Q4. What are the major segments for digital pathology market?
Answer: The future of the digital pathology market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes.
Q5. Who are the key digital pathology companies?
Answer: Some of the key digital pathology companies are as follows:
• Leica Biosystems
• Koninklijke Philips N.V.
• Hamamatsu Photonics
• F. Hoffmann-La Roche
• 3DHISTECH
• Apollo Enterprise Imaging
• XIFIN
• Visiopharm A/S
• Aiforia Technologies Oy
• Akoya Biosciences
• Corista
Q6. Which digital pathology segment will be the largest in future?
Answer:Lucintel forecasts that scanners will remain the larger segment over the forecast period because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.
Q7. In digital pathology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to the increasing prevalence of cancer, growing adoption of digital imaging and presence of key market players in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the digital pathology market by product (scanners, software, and storage systems), type (human pathology and veterinary pathology), application (drug discovery, disease diagnosis, and training & education), end use (pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents